History of Psychedelics
10,000 years of sacred plants, scientific discovery, and the revolution in mental health.
Sacred Origins
The relationship between humans and psychedelic substances stretches back to the very dawn of civilization. Archaeological evidence suggests that humans have been using mind-altering plants and fungi for at least 10,000 years.
In the Tassili n'Ajjer caves of Algeria, rock paintings dating to 7000-9000 BCE depict mushroom-headed figures, suggesting early use of psilocybin mushrooms in North Africa. Similar petroglyphs appear across the globe.
The Rigveda, one of humanity's oldest religious texts (1500 BCE), describes 'Soma' - a sacred drink that bestowed immortality and divine visions. Scholars debate whether Soma was derived from Amanita muscaria mushrooms or another psychoactive plant.
In Mesoamerica, the Aztecs called psilocybin mushrooms 'teonanácatl' (flesh of the gods), using them in sacred ceremonies for healing, divination, and communion with deities. This practice dates back thousands of years.
The Eleusinian Mysteries of ancient Greece (1600 BCE - 392 CE) centered around a sacred drink called 'kykeon.' For nearly 2,000 years, initiates experienced profound visions that shaped Western philosophy and spirituality.
"Psychedelics may have played a crucial role in the development of human consciousness, spirituality, and the birth of religion itself."
Key Substances
Living Wisdom
While Western science 'discovered' psychedelics in the 20th century, indigenous peoples have maintained unbroken traditions of sacred plant use for millennia. These traditions represent humanity's longest-running experiments with consciousness.
In the Amazon, ayahuasca (a DMT-containing brew) has been central to healing and spiritual practices for countless generations. The indigenous knowledge of combining DMT-containing plants with MAO inhibitors represents sophisticated pharmacological understanding.
The Mazatec people of Oaxaca, Mexico, have used psilocybin mushrooms in veladas (all-night healing ceremonies) for centuries. María Sabina, a Mazatec curandera, would later become instrumental in introducing these practices to the West.
The Native American Church, formed in the late 19th century, centers around the ceremonial use of peyote. This tradition blends indigenous practices with Christian elements and now has legal protection in the United States.
These traditions share common elements: ceremonial contexts, guidance from experienced practitioners, integration of experiences, and profound respect for the substances as sacred teachers rather than recreational drugs.
"Indigenous traditions remind us that psychedelics are not merely chemicals but technologies for healing, community building, and spiritual growth when used with proper guidance and intention."
The Laboratory Age
The modern scientific study of psychedelics began in 1897 when German chemist Arthur Heffter isolated mescaline from the peyote cactus - the first psychedelic compound ever extracted and identified.
In 1938, Swiss chemist Albert Hofmann at Sandoz Laboratories synthesized lysergic acid diethylamide (LSD-25) while researching compounds from ergot fungus. The substance was set aside as uninteresting.
Five years later, on April 19, 1943, Hofmann accidentally absorbed a small amount of LSD through his fingertips. Experiencing strange sensations, he intentionally took a larger dose and rode his bicycle home - experiencing the world's first intentional acid trip. This date is now celebrated as 'Bicycle Day.'
Hofmann described his experience: 'Kaleidoscopic, fantastic images surged in on me, alternating, variegated, opening and then closing themselves in circles and spirals... sounds were transposed into visual sensations.'
Sandoz began distributing LSD to researchers worldwide under the trade name 'Delysid,' marketing it as a tool for psychiatrists to understand the minds of their patients and as an adjunct to psychotherapy.
"April 19, 1943 - 'Bicycle Day' - marks the birth of the psychedelic era, when Albert Hofmann discovered the profound effects of LSD."
Key Figures
Key Substances
Psychiatric Promise
The 1950s and early 1960s represented a golden age of psychedelic research. Over 1,000 clinical papers were published, involving more than 40,000 patients. LSD was considered one of the most promising tools in psychiatry.
Humphry Osmond, a British psychiatrist, pioneered the use of LSD for treating alcoholism in Saskatchewan, Canada. His studies showed remarkable success rates - some reports indicated over 50% of chronic alcoholics remained sober after a single high-dose LSD session.
Osmond coined the term 'psychedelic' (meaning 'mind-manifesting') in 1956 in correspondence with writer Aldous Huxley, who had documented his mescaline experience in 'The Doors of Perception' (1954).
At Harvard University, Timothy Leary and Richard Alpert (later Ram Dass) launched the Harvard Psilocybin Project in 1960, conducting experiments with psilocybin including the famous 'Marsh Chapel Experiment' which demonstrated mystical experiences in a religious context.
Meanwhile, the CIA's Project MKUltra secretly explored LSD as a potential mind-control agent, conducting often unethical experiments. When exposed, this program would contribute to psychedelics' controversial reputation.
"During this era, LSD was considered a revolutionary psychiatric tool, with major institutions and government agencies investing heavily in research."
Key Substances
Cultural Revolution
As LSD escaped the laboratory and entered the broader culture, it became intertwined with the counterculture movement, anti-war protests, and the civil rights movement. Ken Kesey and his Merry Pranksters promoted LSD through their 'Acid Tests.'
Timothy Leary's famous exhortation to 'Turn on, tune in, drop out' captured the utopian hopes many held for psychedelics as tools for personal and social transformation. LSD became a symbol of rebellion against the establishment.
The Summer of Love in 1967 saw hundreds of thousands gather in San Francisco's Haight-Ashbury district, many experiencing psychedelics as part of a vision for a more peaceful, loving society.
Music, art, and literature were profoundly influenced. The Beatles, Jimi Hendrix, and countless others created works inspired by psychedelic experiences. Album covers, concert posters, and fashion reflected the visual aesthetics of altered states.
However, this period also saw casualties from reckless use, bad trips in unsupportive settings, and a moral panic that conflated responsible use with chaos and danger.
"Psychedelics became symbols of an entire generation's hopes for transformation - and its establishment's fears of social upheaval."
Key Substances
The Dark Ages
In 1970, the Controlled Substances Act placed LSD, psilocybin, mescaline, and DMT in Schedule I - the most restrictive category, defined as having 'high potential for abuse' and 'no accepted medical use.' Scientific research effectively stopped.
The Nixon administration explicitly linked drug prohibition to suppressing political opposition. John Ehrlichman later admitted: 'We knew we couldn't make it illegal to be... against the war, but by getting the public to associate... hippies with marijuana and LSD, and then criminalizing both heavily, we could disrupt those communities.'
Research continued in a few places. Stanislav Grof developed holotropic breathwork as a legal alternative. Alexander 'Sasha' Shulgin quietly synthesized and self-tested hundreds of new psychedelic compounds from his home laboratory.
Underground therapy continued despite illegality. Some therapists risked their licenses and freedom to provide psychedelic-assisted therapy to clients who had exhausted other options.
The broader cultural conversation about psychedelics largely fell silent, and a generation grew up with little accurate information about these substances.
"For two decades, promising research into consciousness, addiction, and mental health was frozen. The costs of this halt are still being calculated."
Research Reborn
In 1990, Rick Strassman received FDA approval to study DMT in human subjects - the first government-sanctioned psychedelic research in over 20 years. His book 'DMT: The Spirit Molecule' later introduced a new generation to psychedelics.
The Multidisciplinary Association for Psychedelic Studies (MAPS), founded by Rick Doblin in 1986, began methodically laying groundwork for FDA-approved research, particularly with MDMA for PTSD.
In 2006, Roland Griffiths at Johns Hopkins published a landmark study showing psilocybin could occasion mystical experiences with lasting positive effects on well-being, the first rigorous modern study of its kind.
Research accelerated: NYU and Johns Hopkins demonstrated psilocybin's remarkable efficacy for end-of-life anxiety in terminal cancer patients. Imperial College London's Robin Carhart-Harris began mapping psilocybin's effects on brain networks.
Michael Pollan's 2018 book 'How to Change Your Mind' brought psychedelic science to mainstream audiences, sparking unprecedented public interest and discussion.
"After decades of suppression, rigorous scientific research has resumed, demonstrating remarkable therapeutic potential for depression, addiction, PTSD, and existential distress."
A New Dawn
In November 2020, Oregon became the first U.S. state to legalize psilocybin therapy through Measure 109, creating a regulated framework for therapeutic use. Colorado followed with similar legislation in 2022.
The FDA designated psilocybin as a 'breakthrough therapy' for treatment-resistant depression in 2018, and MDMA received similar designation for PTSD. These designations accelerate the path to approval.
Major universities including Johns Hopkins, NYU, Yale, and UC Berkeley have established dedicated psychedelic research centers, attracting significant philanthropic and institutional funding.
Cities across America - including Denver, Oakland, Seattle, Washington D.C. (Initiative 81), and others - have moved to decriminalize psychedelics, recognizing their low risk profile and potential benefits.
We stand at a historic inflection point. After decades of prohibition, society is reconsidering its relationship with these ancient medicines. The question now is not whether psychedelics will be reintegrated into modern healthcare and culture, but how.
Initiative 81 makes certain non-commercial activities involving specified entheogenic plants and fungi among MPD's lowest enforcement priorities. It does not establish a commercial licensing system or override federal controlled-substance law.
"We are witnessing the end of prohibition and the beginning of a new era of responsible, research-backed psychedelic use."
Continue Your Journey
Ready to learn more? Explore our other educational resources.